ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Obituary: Piotr Kulesza, 46, Pathologist At Northwestern, ECOG-ACRIN, Dies in Fall After Group Meeting

November 22, 2013

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

April 1, 1994

Particle Radiation Working Group Asks Support For Facilities, Trials

June 23, 1978

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014